Ignite Creation Date:
2024-05-06 @ 1:42 PM
Last Modification Date:
2024-10-26 @ 1:18 PM
Study NCT ID:
NCT04091737
Status:
TERMINATED
Last Update Posted:
2021-06-18
First Post:
2019-09-13
Brief Title:
CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease
Sponsor:
CSL Behring
Organization:
CSL Behring
Organization Data
Organization:
CSL Behring
Class:
INDUSTRY
Study ID:
CSL200_1001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CSL Behring
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None